Cell-based therapies in Parkinson's disease
1Department of Neurology, Columbia University Medical Center, New York, NY 10032, USA. greene@neuro.columbia.edu
Current Neurology and Neuroscience Reports
|June 12, 2009
Summary
Stem cell therapy for Parkinson's disease (PD) showed no overall benefit in clinical trials. Further research is needed to address unpredictable outcomes and side effects like dyskinesias.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Clinical Trials
Background:
- Stem cell transplantation is a potential therapy for Parkinson's disease.
- Early open-label studies suggested promise for fetal cell transplantation.
- However, rigorous studies have yielded mixed results.
Purpose of the Study:
- To evaluate the efficacy and safety of stem cell transplantation for Parkinson's disease.
- To investigate the causes of unpredictable benefits and side effects.
- To identify strategies to overcome challenges in dopaminergic cell transplantation.
Main Methods:
- Randomized, double-blind, placebo-controlled trial design.
- Utilized dopaminergic cell transplantation in Parkinson's disease patients.
- Compared outcomes against placebo and assessed for adverse events like dyskinesias.
Main Results:
- Three major randomized controlled trials found no net benefit from stem cell transplantation.
- A significant subset of patients experienced persistent dyskinesias, a movement disorder.
- These dyskinesias occurred even with reduced medication dosages.
Conclusions:
- Current stem cell transplantation approaches for Parkinson's disease lack proven efficacy.
- Unpredictable benefits and treatment-induced dyskinesias remain significant hurdles.
- Further research is essential to refine stem cell therapies for Parkinson's disease.
Related Concept Videos
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.